StockDuty ← Dashboard Nov 20, 2026 05:28 PM ET
SignalCorporate

NGS Reference Materials Market Insights and Competitive Landscape - Forecast to 2036 | Total Revenue to Reach $904.1 Million as Liquid Biopsy and IVD-Grade Standards Drive 10.7% CAGR

Forecast cites $904.1 million revenue and 10.7% CAGR driven by liquid biopsy and IVD-grade standards.

What happened: ResearchAndMarkets.com added a report forecasting the global NGS reference materials market, citing clinical sequencing demand, assay validation needs, and IVD-grade standards as growth drivers. Key numbers: Market valued at USD 293.4 million in 2025, estimated at USD 327.3 million in 2026, Why it matters: Laboratories must validate assays before patient testing and after changes to reagents, instruments, or pipelines, making quality controls a recurring purchase. Growth is constrained by scarce residual patient specimens and budget pressures at smaller laboratories. Market: -3.4% today ($193.75), +44.2% YTD, 0.2x vol — as of 17:17 UTC
ResearchAndMarkets.com added a report forecasting the global NGS reference materials market, citing clinical sequencing demand, assay validation needs, and IVD-grade standards as growth drivers.
Laboratories must validate assays before patient testing and after changes to reagents, instruments, or pipelines, making quality controls a recurring purchase. Growth is constrained by scarce residual patient specimens and budget pressures at smaller laboratories. Market: -3.4% today ($193.75), +44.2% YTD, 0.2x vol — as of 17:17 UTC
Sources